CAR‐Ts: new perspectives in cancer therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

CAR‐Ts: new perspectives in cancer therapy

Published:2022-01-12 Issue:4 Volume:596 Page:403-416
ISSN:0014-5793
Container-title:FEBS Letters
language:en
Short-container-title:FEBS Letters

Author:

Abrantes Rafaela¹²³^ORCID,Duarte Henrique O.¹²^ORCID,Gomes Catarina¹²^ORCID,Wälchli Sébastien⁴^ORCID,Reis Celso A.¹²³⁵^ORCID

Affiliation:

1. i3S Instituto de Investigação e Inovação em Saúde Universidade do Porto Portugal

2. IPATIMUP Institute of Molecular Pathology and Immunology University of Porto Portugal

3. ICBAS Abel Salazar Biomedical Sciences Institute University of Porto Portugal

4. Translational Research Unit Department of Cellular Therapy Oslo University Hospital Norway

5. FMUP Faculty of Medicine University of Porto Portugal

Publisher

Wiley

Subject

Cell Biology,Genetics,Molecular Biology,Biochemistry,Structural Biology,Biophysics

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/1873-3468.14270

Reference87 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

2. Nivolumab in Previously Untreated Melanoma withoutBRAFMutation

3. Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): a phase 2, single-arm trial

4. Pembrolizumab versus Ipilimumab in Advanced Melanoma

5. Adoptive cellular therapy: A race to the finish line

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phage Display as a Medium for Target Therapy Based Drug Discovery, Review and Update;Molecular Biotechnology;2024-06-01

2. Metastatic organotropism: a brief overview;Frontiers in Oncology;2024-04-25

3. T cell receptor signaling and cell immunotherapy;National Science Open;2024-03-15

4. Synthetic Biology Meets Ca2+ Release-Activated Ca2+ Channel-Dependent Immunomodulation;Cells;2024-03-07

5. Omics Applications in Cancer Immunology;Handbook of Cancer and Immunology;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3